NCT07201012View on ClinicalTrials.gov

Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2026

Conditions
Basal Cell Carcinoma of Skin, Site UnspecifiedEpidermoid CarcinomaLynch SyndromeMuir-Torre Syndrome
Interventions
DIAGNOSTIC_TEST

Sampling of suspected skin lesions (in accordance with good care practices).

Sampling of suspected skin lesions (in accordance with good care practices) and swabbing of skin microbiota.

GENETIC

Constitution of a biobank

Collection of previously excised cutaneous and deep tumour lesions kept in a public or private pathological anatomy facility for these patients

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT07201012 - Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome | Biotech Hunter | Biotech Hunter